11.3 Palliative Care, Goals of Care, and End-of-Life Device Management

Quick Overview: Heart failure is a life-limiting illness characterized by high symptom burden, unpredictable clinical trajectories, and complex ethical transitions. The Certified Heart Failure Nurse (CHFN) plays an indispensable role in distinguishing palliative care from terminal hospice care, facilitating proactive advance care planning (ACP), and executing compassionate end-of-life transitions. A paramount nursing competency is the timely, ethical deactivation of implantable cardioverter-defibrillator (ICD) shock therapies—preventing traumatic, painful end-of-life shocks while preserving essential bradycardia pacing.

---

The Spectrum of Supportive Care: Palliative Care vs. Hospice

A pervasive misconception among patients, families, and even healthcare clinicians is that palliative care is synonymous with hospice or imminent death. This misunderstanding leads to tragic delays in symptom management and supportive interventions:

┌─────────────────────────────────────────────────────────────────────────────┐
│                     Palliative Care vs. Hospice Continuum                   │
├──────────────────────────┬──────────────────────────────────────────────────┤
│ Feature                  │ Palliative Care (Concurrent Care)                │
├──────────────────────────┼──────────────────────────────────────────────────┤
│ Timing of Initiation │ Integrated early, starting at Stage C        │
│                          │ (symptomatic HF) alongside active GDMT           │
│ Treatment Intent     │ Relieve suffering while pursuing disease-        │
│                          │ modifying, life-prolonging, or curative care     │
│ Prognostic Cutoff    │ No prognostic time limit (months to years)       │
│ Therapy Compatibility│ Continues GDMT, CRT-D, revascularization, and    │
│                          │ advanced evaluation (LVAD / Transplant)          │
├──────────────────────────┼──────────────────────────────────────────────────┤
│ Feature                  │ Hospice Care (Comfort-Focused End-of-Life)       │
├──────────────────────────┼──────────────────────────────────────────────────┤
│ Timing of Initiation │ Transitioned at Stage D (refractory end-     │
│                          │ stage HF) when disease-directed options cease    │
│ Treatment Intent     │ Exclusively comfort-focused; pain, dyspnea, and  │
│                          │ psychosocial-spiritual symptom palliation        │
│ Prognostic Cutoff    │ Certified terminal prognosis ≤ 6 months       │
│                          │ if the disease follows its natural course        │
│ Therapy Compatibility│ Discontinues acute hospitalizations, ICD shocks, │
│                          │ and aggressive invasive hemodynamic monitoring   │
└──────────────────────────┴──────────────────────────────────────────────────┘

Early Palliative Integration (Stage C Heart Failure)

The 2022 AHA/ACC/HFSA guideline recommends palliative and supportive care (Class 1) for patients with heart failure and significant symptoms, and it supports integrating this care early, beginning in Stage C, rather than waiting for the final days of life. Palliative care teams provide specialized symptom management (addressing refractory dyspnea, neuropathic pain, nausea, severe fatigue, insomnia, and depression), assist with complex shared decision-making regarding advanced therapies (LVAD, mechanical circulatory support), and facilitate proactive advance care planning without requiring patients to sacrifice life-prolonging pharmacotherapies.

---

The Unpredictable Heart Failure Disease Trajectory

Effective advance care planning requires that patients and families understand the unique biological trajectory of heart failure. Unlike oncologic trajectories, which often feature a prolonged period of preserved function followed by a rapid, predictable functional decline over weeks to months, heart failure follows a rollercoaster trajectory:

Functional Status
   ^
   │  Trajectory: Gradual decline with intermittent acute drops & partial recoveries
100│  ───┐
   │     │
 75│     └──┐  /\            * Risk of Sudden Cardiac Death (SCD) at ANY point
   │        └──/  \──┐  /\
 50│                 └──/  \──┐  /\
   │                          └──/  \──┐
 25│                                   └──┐
   │                                      └───▶ Hospice / Death
  0└─────────────────────────────────────────────────────────────▶ Time (Years)

Clinical Realities of the Trajectory

1. Unpredictable Decompensation Drops: Each acute decompensation event damages organ beds (worsening cardiorenal syndrome, ischemic myocyte injury) and reduces baseline functional reserve. While aggressive inpatient diuresis and inotropes often produce partial clinical recovery, the patient rarely returns to their prior baseline functional capacity.
2. The Constant Threat of Sudden Cardiac Death (SCD): At any point along the trajectory—even when the patient is feeling relatively stable (NYHA Class II or III)—a malignant ventricular tachyarrhythmia (VT/VF) can precipitate sudden cardiac death.
3. Prognostic Uncertainty: Because patients have survived multiple prior "near-death" hospitalizations and returned home, patients and families often develop a false sense of invulnerability, expecting another recovery even when terminal cardiogenic shock or multi-organ failure has arrived. CHFNs provide compassionate, realistic anticipatory guidance regarding this trajectory.

---

Advance Care Planning (ACP) and Advance Directives

Advance Care Planning (ACP) is an ongoing, iterative communication process wherein patients identify their values, articulate their goals of care, and formulate medical preferences in preparation for future incapacity.

Essential ACP Components

• Healthcare Proxy / Durable Power of Attorney for Healthcare (DPOA-HC): Formally legally designating a trusted surrogate decision-maker who understands the patient's values and is empowered to make medical decisions if the patient loses cognitive or communicative capacity. This should be completed while the patient has full decision-making capacity.
• Living Will: A legal document specifying preferences regarding life-sustaining measures (e.g., cardiopulmonary resuscitation [CPR], mechanical ventilation, artificial enteral nutrition/tube feeding, and continuous hemodialysis) under specific terminal circumstances.
• POLST / MOLST Orders: Physician / Medical Orders for Life-Sustaining Treatment (POLST/MOLST; the national POLST form is now titled Portable Medical Orders) convert broad patient wishes into immediately actionable, standardized, legally binding medical orders signed by a licensed clinician. Unlike living wills (which are legal declarations that require interpretation), POLST orders are actionable across all settings (outpatient, home, EMS, emergency department) and cover specific categories:
  • Cardiopulmonary Resuscitation (CPR vs. DNR / Allow Natural Death).
  • Medical Interventions (Full Treatment vs. Selective Interventions vs. Comfort-Focused Care).
  • Artificially Administered Nutrition and Hydration.

---

Hospice Referral Criteria in Stage D Heart Failure

Transitioning to hospice care becomes indicated when disease-directed medical and device therapies can no longer prevent decline, and the patient prioritizes comfort over aggressive life prolongation.

Clinical Eligibility Criteria

Under Medicare guidelines and heart failure professional consensus, hospice eligibility requires a physician-certified life expectancy of six months or less if the disease follows its expected trajectory. Medicare local coverage guidance for heart disease centers on NYHA Class IV symptoms (or angina at rest) despite optimal treatment with diuretics and vasodilators, or a decision to decline further treatment; supporting factors include LVEF ≤ 20%, treatment-resistant arrhythmias, prior cardiac arrest or unexplained syncope, and cardiogenic embolic stroke. Specific clinical markers include:

1. Stage D Advanced Heart Failure with NYHA Class IV Symptoms: Severe dyspnea, angina, or profound fatigue at rest or with minimal activity (e.g., speaking, brushing teeth, eating).
2. Optimization or Intolerance of GDMT: The patient is either receiving maximally tolerated doses of neurohormonal blockers or has been forced to discontinue them due to symptomatic hypotension (SBP < 80-90 mmHg), severe bradycardia, or advancing cardiorenal failure (worsening azotemia and hyperkalemia).
3. Advanced Therapy Ineligibility or Refusal: The patient is not a candidate for, or explicitly declines, heart transplantation or durable mechanical circulatory support (LVAD).
4. Recurrent Unscheduled Healthcare Utilization: Frequent emergency department visits, observation stays, or hospitalizations for acute decompensated heart failure (e.g., ≥ 2-3 admissions within the prior 6 to 12 months) despite intensive outpatient management.
5. Progressive Cardiac Cachexia & Functional Decline: Unintentional non-edematous weight loss (Medicare's general decline guidance cites more than 10% over 6 months), temporal muscle wasting, and progressive functional dependence (for example, bed- or chair-bound more than half the day, documented with the Palliative Performance Scale).
6. Refractory Congestion or Hypoperfusion: Persistent fluid overload requiring high-dose continuous intravenous loop diuretics or continuous palliative inotropic infusions (milrinone, dobutamine) for symptom palliation.

---

End-of-Life ICD Shock Deactivation: Ethical, Legal, and Clinical Protocol

An implantable cardioverter-defibrillator (ICD) is designed to detect and terminate life-threatening ventricular tachyarrhythmias (VT/VF) by delivering high-energy electrical shocks (30-40 Joules) or antitachycardia pacing (ATP). However, in a dying patient, the terminal dying heart naturally enters ventricular tachycardia, ventricular fibrillation, or agonal rhythms.

┌─────────────────────────────────────────────────────────────────────────────┐
│                     The Tragedy of the Undeactivated ICD                    │
├─────────────────────────────────────────────────────────────────────────────┤
│  Terminal Myocardial Hypoxia & Ischemia ➔ Ventricular Fibrillation (VF)     │
│                                     │                                       │
│                                     ▼                                       │
│  Active ICD Detects VF ➔ Delivers Repeated 35–40 Joule Internal Shocks      │
│                                     │                                       │
│                                     ▼                                       │
│  Patient Experiences Violent Painful Convulsions in Bed During Final Hours  │
│  • Reported in a meaningful minority of patients whose shocks stay active   │
│  • Causes severe trauma, terror, and moral distress to family and nurses    │
│  • Does NOT restore viable life; merely disrupts a peaceful death           │
└─────────────────────────────────────────────────────────────────────────────┘

Ethical and Legal Foundation (Heart Rhythm Society Consensus)

The Heart Rhythm Society (HRS), in consensus with the ACC, AHA, and American Academy of Hospice and Palliative Medicine (AAHPM), affirms that:

• Patients (or their legally appointed healthcare surrogates if the patient lacks capacity) possess the unequivocal ethical and legal right to decline, withhold, or withdraw any life-sustaining medical intervention, including CIED therapies.
• Deactivating ICD shock therapy is legally and ethically distinct from physician-assisted death or euthanasia. It allows the patient to succumb to their underlying terminal cardiac disease naturally without painful, futile electrical cardioversion.
• A clinician who has a moral or religious objection to deactivating a device is ethically obligated to transfer the patient's care to another willing clinician.

Deactivation Strategy: Shocks vs. Pacing

The CHFN must clearly articulate the physiological difference between tachyarrhythmia therapies and bradycardia pacing:

Methods of ICD Deactivation

1. Elective Programmer Deactivation (The Preferred Method):

   • An electrophysiologist, cardiologist, trained device nurse, or manufacturer device representative interrogates the ICD using a specialized telemetry programmer.
   • Tachyarrhythmia detection zones and defibrillator shock therapies (along with ATP) are permanently reprogrammed to "OFF".
   • Pacemaker pacing parameters remain entirely unaltered.
   • Clear documentation is entered in the medical record, and a written device report is placed in the chart.

2. Emergent Bedside Deactivation Using a Clinical Donut Magnet:

   • If a dying patient with an active ICD is admitted to hospice or home care and a device programmer is unavailable, or if an ICD begins firing repeatedly during the dying process, a clinical ring/donut magnet is used immediately.
   • Magnet Mechanics: Placing a clinical donut magnet directly over the ICD generator pocket triggers an internal reed switch or Hall-effect sensor that, in most current ICDs, suspends tachyarrhythmia detection and temporarily disables defibrillator shocks and ATP (a few devices can be programmed to ignore magnets, so confirm with the device clinic).
   • Crucial Magnet Nuance: The magnet MUST REMAIN TAPED SECURELY IN PLACE over the device pocket using medical tape. If the magnet moves or is removed, tachyarrhythmia detection resumes immediately, and shocks will fire again!
   • Preservation of Pacing: Applying a magnet over an ICD does NOT stop or alter bradycardia pacing. (Warning: Placing a magnet over a standard pacemaker switches it to asynchronous pacing at 85–100 bpm, but placing a magnet over an ICD specifically and exclusively disables tachytherapy while leaving underlying pacing intact).

┌─────────────────────────────────────────────────────────────────────────────┐
│                     Clinical Donut Magnet Application                       │
├─────────────────────────────────────────────────────────────────────────────┤
│  1. Locate ICD generator in left (or right) subclavicular pectoral pocket.  │
│  2. Place clinical donut magnet directly over center of generator.          │
│  3. Some devices beep; responses vary by manufacturer, so confirm with EP.  │
│  4. Secure magnet firmly to chest wall with adhesive medical tape.          │
│  5. Keep magnet taped continuously until death occurs or programmer arrives.│
└─────────────────────────────────────────────────────────────────────────────┘

---

Clinical Case Scenario: Navigating Goals of Care and ICD Deactivation

An 82-year-old male with ischemic cardiomyopathy (LVEF 15%, dual-chamber transvenous ICD implanted 6 years ago) has experienced four hospital admissions for acute decompensated heart failure within the past four months. He is severely cachectic, having lost 18 pounds over the past five months, and is confined to a recliner chair with dyspnea at rest (NYHA Class IV). His SBP is 82/50 mmHg, eGFR has declined to 16 mL/min/1.73m², and carvedilol and sacubitril/valsartan had to be discontinued due to profound hypotension.

• Goals of Care Conversation: The CHFN, palliative physician, patient, and his daughter (designated DPOA-HC) hold a structured goals-of-care conference. The patient states clearly: "I have fought hard, but I am exhausted. I want to spend my remaining days at home without going back to the hospital, and I do not want any machines shocking me when my time comes."
• Hospice & POLST Execution: The patient enrolls in home hospice care. A POLST order is executed indicating "Do Not Resuscitate (DNR), Comfort-Focused Care, No Intubation, No Hospital Transfer."
• ICD Management Protocol: The nurse coordinates device management. Because the patient lives in a rural area and a device programmer cannot arrive for 48 hours, the nurse obtains a specialized clinical donut magnet from the palliative care supply. The nurse educates the family that the magnet will silence defibrillator shocks so the patient does not experience violent electrical jolts as his heart slows down, while reassuring them that it will not shut off his basic heartbeat pacemaker or cause him to suffocate.
• Outcome: The magnet is taped securely over the generator pocket. The patient passes away peacefully at home surrounded by his family 36 hours later, free from pain, dyspnea, or traumatic device shocks.

---

CHFN Exam Traps & Clinical Pearls

[!WARNING] Exam Trap: Do not confuse palliative care with hospice care! Palliative care is appropriate at ANY stage of heart failure (starting at Stage C) and is delivered concurrently with guideline-directed medical therapy, CRT-D, and transplant evaluations. Hospice is strictly for Stage D end-stage heart failure with a certified prognosis of ≤ 6 months when disease-directed therapies are surrendered for comfort.

[!IMPORTANT] Clinical Pearl: Always remember the effect of a magnet on an ICD! Placing a magnet over an ICD disables tachyarrhythmia detection and defibrillator shocks, but does NOT disable bradycardia pacing. Pacemaker-dependent patients will continue to receive life-sustaining pacing spikes, preventing acute symptomatic bradycardia.

[!TIP] Exam Trap: Understand the legal and ethical consensus regarding ICD deactivation: A patient or surrogate has the absolute legal and ethical right to request ICD shock deactivation at any time. Deactivating an ICD is NOT assisted suicide, euthanasia, or neglect; it simply allows natural death from the underlying heart failure without painful electrical shocks.